Flatiron Health Announces New Partnership in the UK

Article

Expansion into UK marks company’s third international subsidiary.

Contrast injector for CT examination. Innovative technologies in medicine. Image Credit: Adobe Stock Images/Ravil Sayfullin

Image Credit: Adobe Stock Images/Ravil Sayfullin

Flatiron Health, an oncology-focused RWD technology company, has partnered with the Leeds Teaching Hospitals NHS Trust (LTHT), one of largest acute hospital trusts in Europe. The entry into the United Kingdom marks a major milestone in Flatiron’s expansion.

Flatiron International has subsidiaries already in Japan and Germany. Each partners with hospitals and health networks in RWD collaborations through Flatiron's local teams and infrastructure, ensuring that strict legal and regulatory requirements are met in all locations. The goal is to produce more top-quality oncology datasets for use by Flatiron’s hospital and health network partners in research collaborations and under license—with specific terms and conditions—to biopharma companies, to accelerate cancer research.

“Each Flatiron International partnership is designed to help local healthcare providers and partners generate and utilize high-quality RWD to advance oncology research and care,” said Nathan Hubbard, SVP, Flatiron’s head of corporate development and Flatiron International. He noted that the agreement was approved by the NHS Health Research Authority.

Reference: Flatiron Health Announces New Partnership in the UK, June 20, 2023.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.